Explain factors that might impact the patient’s pharmacokinetic and pharmacodynamic processes

Topic:nnAssessingnnSubjectnnNursingnnThe AssignmentnnExamine Case Study: An African American Child Suffering From Depression. You will be asked to make three decisions concerning the medication to prescribe to this client. Be sure to consider factors that might impact the client’s pharmacokinetic and pharmacodynamic processes.nnAt each decision point stop to complete the following:nDecision #1nWhich decision did you select?nWhy did you select this decision? Support your response with evidence and references to the Learning Resources.nWhat were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.nExplain any difference between what you expected to achieve with Decision #1 and the results of the decision. Why were they different?nDecision #2nWhy did you select this decision? Support your response with evidence and references to the Learning Resources.nWhat were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.nExplain any difference between what you expected to achieve with Decision #2 and the results of the decision. Why were they different?nDecision #3nWhy did you select this decision? Support your response with evidence and references to the Learning Resources.nWhat were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.nExplain any difference between what you expected to achieve with Decision #3 and the results of the decision. Why were they different?nAlso include how ethical considerations might impact your treatment plan and communication with clients.nNote: Support your rationale with a minimum of three academic resources. While you may use the course text to support your rationale, it will not count toward the resource requirement.nnRequired ReadingsnnStahl, S. M. (2013). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). New York, NY: Cambridge University Press.nnChapter 6, “Mood Disorders”nChapter 7, “Antidepressants”nStahl, S. M. (2014b). The prescriber’s guide (5th ed.). New York, NY: Cambridge University Press.nnTherapy for Pediatric Clients with Mood DisordersnAn African American Child Suffering From DepressionnAfrican American ChildnnnBACKGROUND INFORMATIONnnThe client is an 8-year-old African American male who arrives at the ER with his mother. He is exhibiting signs of depression.nClient complained of feeling “sad”nMother reports that teacher said child is withdrawn from peers in classnMother notes decreased appetite and occasional periods of irritationnClient reached all developmental landmarks at appropriate agesnPhysical exam unremarkablenLaboratory studies WNLnChild referred to psychiatry for evaluationnClient seen by Psychiatric Nurse PractitionernnMENTAL STATUS EXAMnnAlert & oriented X 3, speech clear, coherent, goal directed, spontaneous. Self-reported mood is “sad”. Affect somewhat blunted, but child smiled appropriately at various points throughout the clinical interview. He denies visual or auditory hallucinations. No delusional or paranoid thought processes noted. Judgment and insight appear to be age-appropriate. He is not endorsing active suicidal ideation, but does admit that he often thinks about himself being dead and what it would be like to be dead.nnThe PMHNP administers the Children’s Depression Rating Scale, obtaining a score of 30 (indicating significant depression)nnnRESOURCESnn§ Poznanski, E., & Mokros, H. (1996). Child Depression Rating Scale–Revised. Los Angeles, CA: Western Psychological Services.nnnDecision Point OnenSelect what the PMHNP should do:nnBegin Zoloft 25 mg orally dailynBegin Paxil 10 mg orally dailynBegin Wellbutrin 75 mg orally BIDnn